"We Envision Growth Strategies Most Suited
to Your Business"
Amid recent advancements associated with the debut of AI in the medical imaging industry, a team of researchers at the National Defense Medical Center, Taiwan, unveiled a new AI algorithm that could improve screening through DEXA equipment. Published in Radiology in June 2024, the study involved the use of a chest X-ray algorithm for the diagnosis of osteoporosis using DEXA (Dual X-Ray Absorptiometry) test and inferred that identification with AI-enabled chest radiographs helps in the effective diagnosis of more osteoporosis cases. Such studies are likely to make way for new breakthroughs in the field of medical diagnostics as countries across the globe are placing a high emphasis on strengthening their medical imaging infrastructure.
Used for performing scans to measure bone density, DEXA equipment involves deploying of very low amounts of radiation compared to X-rays and finds application in the diagnosis of bone thinning or osteoporosis. According to the Centers for Disease Control and Prevention, osteoporosis affects nearly 1 in 20 men and 1 in 5 women over 50 years of age. With such high numbers, the soaring awareness of bone health and a mounting emphasis on preventive testing are bolstering the need for developing advanced diagnostic solutions. According to Fortune Business Insights, the global market for DEXA equipment is projected to hit a valuation of USD 917.8 million by 2034 from USD 609.7 million in 2026, exhibiting a CAGR of 5.2% over 2026 to 2034.
To develop a strong standing, companies operational in this space are adopting a range of strategic steps. They are entering partnerships focused on enhancing product distribution and incorporating advanced technologies to better their offerings. Companies are also joining forces with other players to achieve their business objectives and enhance their industry footprint.
Based in the U.S., Hologic has a portfolio that supports women’s health and is committed to developing technologies that promote a healthier world. The company’s skeletal health portfolio is focused on the diagnosis and treatment of osteoporosis and other bone related concerns in women, with Horizon® DXA System being a major offering. This product has been developed for assessing fracture risk, measuring bone density, and the analysis of body composition.
GE Healthcare provides a range of clinical accessories and products catering to bone and metabolic health. The S.-based company has an annual R&D spend of ~USD 5.1 billion, as per figures available on their website, which reflects a strong emphasis on innovation and product launches. The company’s inclination toward product introduction can be seen in its June 2025 move, when it rolled out Definium Pace Select ET, a new floor-mounted digital X-ray system for high-throughput settings.
FUJIFILM Holdings Corporation, with headquarters in Japan, is centered on providing effective osteoporosis solutions and bone densitometry systems. The DEXA equipment company is committed to improving healthcare infrastructure through its advanced solutions, with ALPHYS LF and ALPHYS A being a few major offerings. In February 2024, FUJIFILM India announced its installation of the FDX Visionary-DR, a powerful DEXA machine, at the inauguration of Delhi-based Center for Sports Injury in India. The new equipment has been installed for providing rapid and high-quality bone-density scans for the diagnosis of bone-related health conditions.
DMS Imaging is centered on the production of medical imaging systems for bone densitometry and digital radiology. The company participated in the 2025 European Congress of Radiology (ECR), held in February-March 2025, to showcase its innovations, including its 3D-DXA technology compatible Stratos DR high-end bone densitometry system, Onyx, and M1 in ADAM version.
Swissray, based in Taiwan, is centered on providing a range of densitometry equipment. The company develops highly efficient medical device solutions. The Norland DXA Densitometer is a key range offered by the company, with ELITE, XR-600, and XR-800 being some of the major offerings. These products are known for their precision and seamless integration to the user interface.
OsteoSys Co., Ltd., one of the top 10 DEXA equipment companies, is focused on the development of various solutions for bone mineral densitometry. DEXXUM T Quantum is a significant offering of this South Korea-based company, which shows a greater emphasis on innovation and bringing new products to the market. In August 2024, the company secured the CE mark under the EU MDR for all its DXA systems, including EXA-3000, PRIMUS, DEXXUM T, EXCELLUS, and DEXXUM T QUANTUM.
Sweden-headquartered Scanflex Healthcare has created its mark in the production of high quality solutions in the areas of medical imaging, personal radiation protection, and bone densitometry. The company’s Scanflex Demetech is known for the development and production of systems for the early diagnosis of osteoporosis.
Established in 2009, South Korea-based Medonica is centered on the expansion of its product portfolio and enhancing the quality of its services. A significant bone densitometer offered by the company is OSTEO Prime. With an emphasis on introducing new X-ray machine models including digital systems, this DEXA equipment player is keen to equip public hospitals and private clinics with its quality offerings.
BeamMed is known for the manufacturing and marketing of bone health-related early assessment and monitoring products. The Israel-based player was established in 2004 and is keen to address the widespread health concern of osteoporosis. In September 2024, the company announced its participation in the NAACOS Fall 2024 Conference to exhibit its innovative MiniOmni Portable Bone Density Scanner. This move is likely to strengthen its position in the medical imaging equipment sector.
Ranked under the top 10 DEXA equipment companies, Shenzhen XRAY Electric Co., Ltd, founded in 2002, is focused on the development of a range of medical vehicles and chamber X-ray machines. With headquarters in China, this DEXA equipment company has a range of bone mineral densitometers, DEXA machines, and X-ray machines, among others.
Over the forthcoming years, the mounting bone health awareness is likely to drive a boost in preventive checkups, elevating DEXA equipment demand. Investments in the equipment across various countries is further poised to support such programs. U.K.’s March 2026 GBP 2.6 million (~USD 3.48 million) investment in 20 new DEXA bone scanners to be deployed across England, is a significant example of preventive care initiatives. Impelled by such steps, the product adoption is anticipated to see a rise in imaging facilities and hospital settings, as these establishments are set to play a significant role in such preventive screening and bone density testing initiatives.
+1 833 909 2966 ( Toll Free ) (US)
sales@fortunebusinessinsights.com